Key Features

  • Brain region segmentation
  • Contrast image synthesis
  • Degree of myelination

General Information

Product name

SyMRI NEURO

Subspeciality

Neuro

Modality

MR

Disease targeted

Multiple sclerosis, atrophy, dementia, neurogenerative diseases

Main task

Not specified

Technical Specifications

Population

Not specified

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

04-2017

AI Platforms

GE Healthcare, Siemens Healthineers

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Evidence & Research

No research papers or evidence available for this product.

Source: public | First published: Jan 30, 2020 | Last updated: Jul 9, 2025